Invention Application
- Patent Title: ARYL DIHYDROPYRIDINONES AND PIPERIDINONE MGAT2 INHIBITORS
-
Application No.: US15488642Application Date: 2017-04-17
-
Publication No.: US20170216263A1Publication Date: 2017-08-03
- Inventor: Huji Turdi , Jon J. Hangeland , R. Michael Lawrence , Dong Cheng , Saleem Ahmad , Wei Meng , Robert Paul Brigance , Pratik Devasthale , Guohua Zhao
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Main IPC: A61K31/438
- IPC: A61K31/438 ; A61K31/5377 ; A61K31/4439 ; A61K31/4418 ; A61K45/06 ; C07D401/14 ; C07D417/14 ; C07D407/14 ; C07D417/04 ; C07D413/12 ; C07D405/14 ; C07D401/12 ; C07D211/86 ; C07D211/90 ; C07D401/10 ; A61K31/675
Abstract:
The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.
Public/Granted literature
- US09901572B2 Aryl dihydropyridinones and piperidinone MGAT2 inhibitors Public/Granted day:2018-02-27
Information query
